Express Scripts, the largest U.S. pharmacy benefit manager, has excluded Onglyza (saxagliptin), a type 2 diabetes medication, and Kombiglyze XR ata gliptin plus metformin, from insurance coverage. That means that patients using this drug may have to pay the full retail price for it. Why…
Over the past few years, health experts have been questioning the effectiveness of testosterone replacement drugs for helping men to improve their sexual function and quality of life. Though products like Androderm and AndroGel have become very popular, some studies have linked them with a…
On May 15, 2015, the Food and Drug Administration (FDA) released a drug safety communication warning doctors and patients about serious side effects associated with type 2 diabetes medication Invokana (canagliflozen), and other similar medications. Since that warning, Invokana attorneys have been in
An FDA advisory panel has recommended that Onglyza (saxagliptin), a type 2 diabetes medication, should have its warning label updated to indicate that it could increase risk of heart failure. Onglyza belongs to a class of drugs known as “dipeptidyl peptidase-4 (DDP-4) inhibitors.” Also called…
The number of Zofran lawsuits filed across the country continues to increase. Moms who took Zofran for morning sickness during pregnancy and then gave birth to babies with birth defects now seek to hold manufacturer GlaxoSmithKline (GSK) liable for medical expenses. Considering the growing litigatio
On August 17, 2015, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Bard IVC filter lawsuits into one court in the District of Arizona. They assigned District Judge David G. Campbell to oversee the coordinated proceedings. A total of 22 cases were…
According to a study recently published in the Journal of the American Medical Association, the use of inferior vena cava (IVC) filters among patients with severe pulmonary embolism (PE) provides no additional health benefits over using anticoagulant medications alone—and may cause additional seriou
An FDA advisory panel has recommended that Onglyza (saxagliptin), a type 2 diabetes medication, should have its warning label updated to indicate that it could increase risk of heart failure. Onglyza belongs to a class of drugs known as “dipeptidyl peptidase-4 (DDP-4) inhibitors.” Also called…
In May 2015, the FDA warned that type 2 diabetes drugs like Invokana could have a potentially dangerous side effect: diabetic ketoacidosis (DKA). This is a serious condition in which the blood becomes too acidic, and can lead to complications like dehydration, coma, and even…
According to a study recently published in the Journal of the American Medical Association, the use of inferior vena cava (IVC) filters among patients with severe pulmonary embolism (PE) provides no additional health benefits over using anticoagulant medications alone—and may cause additional seriou
We’ve all seen direct-to-consumer advertisements for medications. They usually show people improving over a short period of time, and experiencing a much more vibrant and exciting life after taking the company’s drug. Though the side effects are usually listed, the overall messages in these advertis
The number of Zofran lawsuits filed in courts around the country continues to increase. Parents claim that Zofran manufacturers GlaxoSmithKline (GSK) failed to provide adequate warnings about the risks of birth defects when the medication is taken by pregnant women. Considering the rising litigation